Profile data is unavailable for this security.
About the company
Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and sales of chemical medicines. The Company's products are mainly applied as urinary system medicines, antihistamines and cardiovascular medicines. The Company's products include Epristeride Tablets, Ebastine Tablets, Felodipine Tablets, Felodipine Sustained Release Capsules, Simvastatin Tablets, Lumbrokinase Capsulesand and Balofloxacin Tablets. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)2.34bn
- Net income in CNY138.87m
- Incorporated2000
- Employees1.30k
- LocationJiangsu Lianhuan Pharmaceutical Co LtdNo.21, Wenfeng RoadYANGZHOU 225127ChinaCHN
- Phone+86 51 487813082
- Fax+86 51 487815079
- Websitehttp://www.lhpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frontier Biotechnologies Inc | 133.67m | -279.96m | 2.90bn | 395.00 | -- | 2.53 | -- | 21.72 | -0.7474 | -0.7474 | 0.3569 | 3.07 | 0.0636 | 1.61 | 2.72 | 338,416.90 | -13.31 | -14.05 | -16.40 | -15.78 | 33.62 | 2.35 | -209.43 | -450.08 | 2.02 | -- | 0.2808 | -- | 34.82 | 126.63 | 7.79 | -- | 28.13 | -- |
| Ningbo Menovo Pharmaceutical Co Ltd | 1.24bn | 20.30m | 3.07bn | 2.35k | 161.26 | 1.41 | -- | 2.48 | 0.087 | 0.087 | 5.70 | 9.92 | 0.267 | 1.18 | 4.91 | 525,730.80 | 0.5164 | 4.94 | 0.7951 | 7.83 | 29.01 | 35.39 | 1.93 | 13.71 | 0.7203 | 4.44 | 0.4199 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.34bn | 138.87m | 3.09bn | 1.30k | 22.22 | 2.20 | -- | 1.32 | 0.4865 | 0.4865 | 8.18 | 4.92 | 0.8003 | 3.34 | 4.76 | 1,801,909.00 | 5.42 | 5.93 | 11.26 | 11.25 | 49.14 | 53.26 | 6.78 | 7.82 | 0.7061 | 6.61 | 0.3593 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.97bn | 89.38m | 3.14bn | 2.35k | 36.11 | 2.00 | -- | 1.60 | 0.1515 | 0.1515 | 3.39 | 2.74 | 0.5571 | 2.93 | 2.06 | 836,256.80 | 2.67 | 0.272 | 5.80 | 0.4981 | 27.64 | 27.97 | 4.79 | 0.5501 | 0.8146 | 2.65 | 0.3911 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 505.58m | -84.79m | 3.20bn | 1.39k | -- | 1.90 | -- | 6.32 | -0.2245 | -0.2245 | 1.34 | 4.44 | 0.2408 | 2.86 | 13.81 | 365,039.00 | -3.93 | -0.7573 | -4.52 | -0.8713 | 50.29 | 58.02 | -16.32 | -2.45 | 1.04 | -- | 0.1236 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
| GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.40bn | -235.62m | 3.23bn | 5.51k | -- | 1.22 | -- | 1.35 | -0.2975 | -0.2975 | 3.03 | 3.34 | 0.5288 | 1.52 | 13.04 | 435,209.10 | -5.39 | 0.8648 | -6.97 | 1.18 | 61.81 | 74.87 | -10.19 | 1.45 | 1.36 | -9.98 | 0.2375 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Data as of Nov 14 2024. Currency figures normalised to Jiangsu Lianhuan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 1.55m | 0.54% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 251.40k | 0.09% |
| Baoying Fund Management Co., Ltd.as of 30 Jun 2024 | 120.00k | 0.04% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 21.90k | 0.01% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 20.70k | 0.01% |
| Sealand Securities Co., Ltd. (Investment Management)as of 30 Jun 2024 | 16.90k | 0.01% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 16.50k | 0.01% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2024 | 4.30k | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 4.00k | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 3.70k | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
